Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yurii S Moroz

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Journal of Medicinal Chemistry|July 3, 2026
Library Docking for Cannabinoid-2 Receptor LigandsMoira M Rachman, Christos Iliopoulos-Tsoutsouvas, Michael D Sacco, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2023
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Nature Communications|February 18, 2025
Virtual fragment screening for DNA repair inhibitors in vast chemical spaceAndreas Luttens, Duc Duy Vo, Emma R Scaletti, et al.
Journal of Medicinal Chemistry|February 19, 2026
Large Library Docking for PolypharmacologyYujin Wu, Seth Vigneron, Joao Braz, et al.
Science (New York, N.Y.)|September 29, 2022
Structure-based discovery of nonopioid analgesics acting through the α<sub>2A</sub>-adrenergic receptorElissa A Fink, Jun Xu, Harald Hübner, et al.
Journal of Medicinal Chemistry|June 9, 2023
Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-MethyltransferaseIsha Singh, Fengling Li, Elissa A Fink, et al.
Journal of Medicinal Chemistry|June 25, 2024
Development of a Potent and Selective G2A (GPR132) AgonistVictor Hernandez-Olmos, Jan Heering, Beatrice Marinescu, et al.
Nature Communications|March 5, 2025
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Large library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Protein Science : a Publication of the Protein Society|June 24, 2023
Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitorsElissa A Fink, Conner Bardine, Stefan Gahbauer, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Journal of Medicinal Chemistry|July 3, 2026
Library Docking for Cannabinoid-2 Receptor LigandsMoira M Rachman, Christos Iliopoulos-Tsoutsouvas, Michael D Sacco, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2023
Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2Stefan Gahbauer, Galen J Correy, Marion Schuller, et al.
Nature Communications|February 18, 2025
Virtual fragment screening for DNA repair inhibitors in vast chemical spaceAndreas Luttens, Duc Duy Vo, Emma R Scaletti, et al.
Journal of Medicinal Chemistry|February 19, 2026
Large Library Docking for PolypharmacologyYujin Wu, Seth Vigneron, Joao Braz, et al.
Science (New York, N.Y.)|September 29, 2022
Structure-based discovery of nonopioid analgesics acting through the α<sub>2A</sub>-adrenergic receptorElissa A Fink, Jun Xu, Harald Hübner, et al.
Journal of Medicinal Chemistry|June 9, 2023
Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-MethyltransferaseIsha Singh, Fengling Li, Elissa A Fink, et al.
Journal of Medicinal Chemistry|June 25, 2024
Development of a Potent and Selective G2A (GPR132) AgonistVictor Hernandez-Olmos, Jan Heering, Beatrice Marinescu, et al.
Nature Communications|March 5, 2025
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Large library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Protein Science : a Publication of the Protein Society|June 24, 2023
Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitorsElissa A Fink, Conner Bardine, Stefan Gahbauer, et al.
Pageof 11